There are many reasons why people start using legal or illicit drugs like opioids. Oftentimes, the reason is to deal with life stressors or to address physical pain. According to available data, as much as 20.6 million people are abusing drugs in the U.S alone. Although the initial decision to consume drugs may be voluntary or due to legitimate prescriptions, its continuous use can lead to addiction for many. There is a serious opioid epidemic facing the US and other countries, and one company is trying to make a difference.
A Competent Leader
The CEO of the company, Brady Granier, has an academic background in Nursing and his career includes various managerial and directorial roles in media corporations where he dealt with many popular brands. Prior to joining BioCorRx in June of 2013, Brady Granier had been involved in sales management, media sales, and business development. He was employed at Clear Channel Media & Entertainment (“CCME)” which is now iHeart Media, where he had served in several positions starting from Account Executive to Director of Business Development and Local Sales Manager. He has also served as the Healthcare Category Manager for the Los Angeles division of CCME, the largest media company in the United States.
Integrated Treatment Therapy
The company started out only treating alcoholism, but the emergence of the opioid epidemic directed its focus to combatting this problem as well. The opioid crisis began in the United States in late 1990s. Opioids are a class of drugs which includes prescribed painkillers, as well as illegal heroin. The potency of such drugs has made them highly popular for both medicinal and recreational uses, and their addictive nature has fueled the epidemic. Deaths due to drug overdose rose to more than 50,000 in 2015, and almost half of those were from prescription drugs. Such high numbers are more than sufficient for the problem to be categorized as an epidemic by several governmental agencies. The epidemic has cost the United States economy over $500 billion in 2015 alone.
In an attempt to curb this continuing threat, BioCorRx offers naltrexone in the form of a biodegradable implant that dissolves over months, thereby releasing naltrexone into the bloodstream in a sustained manner. The opioid antagonist medication can reduce cravings for alcohol and opioids and can also block many of the effects of such substances. With the widespread problem of addiction due in part to prescription drugs, this treatment has the potential to make a real difference to society. The implant can work well to remove cravings and protect from relapse while the implant is releasing therapeutic levels of naltrexone, but once the cravings are reduced or eliminated, the underlying reasons for the addiction should be addressed. This can be challenging, as each situation is different. To address this, BioCorRx developed a cognitive behavioral therapy (CBT) and peer recovery support program around the naltrexone implant to aid in addressing the psycho-social aspects of the addiction and provide ongoing recovery support. The combination of this medication withCBT and peer support is called the Biocorrx Recovery Program.
Cutting Edge Offerings
BioCorRx offers a medication-assisted treatment (MAT) recovery program which is used to treat both alcohol and opioid use disorders. The following are the unique offerings of the company
- Proprietary Naltrexone Implant is used per patient prescription under state and federal compounding rules. The process of treatment is a simple outpatient procedure performed by a licensed medical professional. During the procedure, the doctor inserts the implant in the patient’s fatty tissue usually in the abdominal area. The entire procedure usually takes only 20-30 minutes and patients typically report that within hours they notice as reduction in cravings.
- Proprietary Cognitive Behavioral Therapy (CBT) Program/Peer Support/Tracking in which patients have access to 35 treatment modules designed to be completed in 16 private sessions, in under 90 days. The modules are now available to patient via mobile app or in workbook form. The peer support is done via mobile app that tracks engagement and patient progress.
- Recovery Program is distributed by partner clinics across the US and fees are paid to BioCorRx per program sold by independent treatment providers. At present, there are approximately a dozen partner clinics available.
Notable Feats BioCorRx expects to get FDA approval for its lead candidate BICX102, which is a naltrexone implant similar to the one used in the BioCorRx Recovery Program. The company secured a grant from the National Institute on Drug Abuse (NIDA) for nearly $5.7 million dollars in Q1 2019 for that product. The company also recently announced the upcoming launch of a new weight loss program called UnCraveRx as well as a $6 million funding related to this new program.
Clients Beating Addiction with BioCorRx
Former child actor Jeremy Miller said “I finally found something that worked for me”. Jeremy’s mom found the naltrexone implant procedure by BioCorRx on the internet.
Jeremy went ahead and had the naltrexone implant procedure done and the medication assisted treatment blocked his cravings for alcohol. “I have to tell you it worked amazingly. It absolutely saved my marriage and my wife thanks God for it each and every day.” Jeremy now helps other patients that enter the BioCorRx Recovery Program.
The post BioCoRX, Inc.: Improving Life with Extensive Addiction Recovery Service appeared first on InsightsSuccess.
This post first appeared on Insights Success Is The Best Business Magazine In The World For Enterprises, please read the originial post: here